Ask Us
Please correct the highlighted fields below.

Alerts for Ibandronate Sodium

Title Date Published Source
FDA Reviewing of Oral Bisphosphonates and Potential Increased Risk of Esophageal Cancer 2011-07-22
Healthcare Professionals Advised Of Potential Risk Of Atypical Fractures of the Thigh With Bisphosphonates 2011-06-07
Europäische Arzneimittelbehörde warnt vor Knochenbrüchen am Oberschenkel durch Osteoporose-Medikamente 2011-05-19
Benefits of Bisphosphonates Continue to Outweigh Risks 2011-05-06
La Agencia Europea De Medicamentos Revisa La Seguridad De Los Bisfosfonatos 2011-05-02
Genentech Informs Customers of Important Information About Alcohol Prep Pads in Injectable Medicine Kits 2011-01-18
Europe-wide Review Shows Insufficient Evidence To Prove Link Between Oral Biphosphonates And Oesophageal Cancer 2010-12-14
FDA Updates Prescribing Information to Warn of Possible Fracture Risk With Osteoporosis Drugs 2010-10-13
European Medicines Agency To Review Safety of Bisphosphonates 2010-09-24
FDA Issues Statement on Possible Increased Risk of Rare Bone Fractures with Long-Term Bisphosphonate Use 2010-09-19
Update on FDA Safety Review of Bisphosphonates 2008-11-14
New Consumer Guide for Patients 2008-07-03
FDA Communication Regarding Musculoskeletal Pain 2008-01-07
Early communication of ongoing safety review 2007-10-01

See alerts for all drugs